Sincere Co., LTD.

7782.T
Medical Instruments & Supplies
2026/11/13 19:59 Updated
Market Cap: $20.6M (¥3.3B)
Stock Price: $3.12 (¥499)
Exchange Rate: 1 USD = ¥159.74

Notice of Revision to Earnings Guidance (Upward Revision)

Revised upward the consolidated earnings guidance for the fiscal year ending December 2026. Revenue increased by 119 million yen from the previous forecast, operating income +49 million yen, ordinary income +91 million yen, net income attributable to owners of parent +35 million yen, and earnings per share raised to 43.10 yen.

Importance:
Page Updated: November 14, 2026
IR Disclosure Date: November 13, 2026

Key Figures

  • Revenue: 7,776 million yen
  • Operating Income: 437 million yen
  • Ordinary Income: 454 million yen

AI要約

Summary of Revision to Earnings Guidance

The Company has revised its consolidated earnings guidance for the fiscal year ending December 2026, increasing revenue from the previous forecast. On the profit side, sales of the high-margin brand "Sincere One-Day S Cresche" exceeded plans, resulting in upward revisions to operating income, ordinary income, and net income. Overall, revenue is expected to progress in line with the revised plan.

Shareholder Value and Future Outlook

Due to expanded sales of high-margin products, full-year net income and earnings per share have been revised upward. Continued growth is expected depending on market demand trends and brand strategy. Actual results may differ as these are forecasts based on information available at the time of disclosure and are subject to change depending on future developments.

Revenue Trend

Operating Income Trend

Ordinary Income Trend

Net Income Attributable to Owners of Parent Trend

Earnings Per Share

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Sincere Co., LTD.

Company overview · Stock price · Financial data · All IR

View company page →